$Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia$
Cover image not available

Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia

National Institute for Health and Clinical Excellence

Publication Data

Title Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
Author National Institute for Health and Clinical Excellence
Publisher National Institute for Health and Clinical Excellence
Publication date 2010
Publication location London
Language English

Descriptive Notes

Issue date: July 2010; Review date: December 2010.
"The guidance was developed using the NICE single technology appraisal process."
Publisher's number: N2241.

Topics

Chronic lymphocytic leukemia :: Chemotherapy
Rituximab

Catalogue Data

OBNB ID GBB586470
ISBN 10 n/a
ISBN 13 n/a
Type BibliographicResource, Book
Dewey Classification 616.99419061

ISBD

P1053 1 online resource (2 unnumbered pages).
P1042 Includes bibliographical references.

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.